TMDX Q3 2025 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$144M+32.2% YoY

Gross Profit

$85M58.8% margin

Operating Income

$23M16.2% margin

Net Income

$24M16.9% margin

EPS (Diluted)

$0.66

QoQ Revenue Growth

-8.6%

Cash Flow

Operating Cash Flow

$70M

Free Cash Flow

$62M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$946M

Total Liabilities

$591M

Stockholders' Equity

$355M

Cash & Equivalents

$466M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$144M	$109M	+32.2%
Gross Profit	$85M	$61M	+39.0%
Operating Income	$23M	$4M	+493.9%
Net Income	$24M	$4M	+476.8%

Revenue Segments

Product

$88M61%

Service

$56M39%